Clinical Trial Detail

NCT ID NCT01627041
Title Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

acute monocytic leukemia

acute myeloid leukemia

Therapies

Cytarabine + Daunorubicin + Decitabine

Cytarabine + Daunorubicin

Age Groups: adult

No variant requirements are available.